Watch this Pharma roundtable video to gain insights into:
How Industry 4.0 can enhance quality, productivity, speed and flexibility to achieve higher levels of integration across the value chain and the entire product lifecycle.- The fundamentals required for the successful adoption and implementation of smart manufacturing innovations within the pharma life sciences manufacturing environment.
- Best practices for handling plant data, including the options available to enable optimized analysis and enhanced decision-making.
- Leveraging automation and digital tools to mitigate risk, enhance quality, reduce anomalies and minimize downtime.
Panelists:
- Moiz Diwan, Director, Head of Enabling Technology Group, Abbvie
- Domagoj Dinter, Director, Global Business Owner MES, Teva Pharmaceuticals
- Giovanni Giorgio, Senior Digital Engineer, Front End Engineering and Design, GSK
- David Eisenberg, Manufacturing Systems Business Lead, Pfizer
- Crick Waters, SVP Enterprise, Falkonry
Pharmaceutical manufacturers must accelerate production activities to meet increased global demand, however, operating in a highly regulated environment generates unique challenges. This strategic awareness has motivated many pharma companies to carry out a retrospective assessment of manufacturing operations, and to identify suitable areas of focus for digital optimization.
Enter your details alongside and watch this roundtable discussion on how Industry 4.0 can enhance quality, productivity, speed and flexibility to achieve higher levels of integration across the value chain and the entire product lifecycle.